CYSTADENOCARCINOMA OVARY

CYSTADENOCARCINOMA OVARY was reported 6 times

CYSTADENOCARCINOMA OVARY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-17A Antagonist [EPC] 1 0.0000
1 Anti-IgE [EPC] 1 0.0000
2 Factor Xa Inhibitor [EPC] 1 0.0000
3 Progestin [EPC] 1 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
5 Corticosteroid [EPC] 1 0.0000